½ÃÀ庸°í¼­
»óǰÄÚµå
1475906

PET MRI ½ÃÀå : Áö¿ªº°(ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«) - ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2031³â)

PET MRI Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 281 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è PET MRI(¾çÀüÀÚ¹æ»ç´ÜÃþÃÔ¿µ ÀÚ±â°ø¸í¿µ»ó) ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ÅëÇØ ½ÃÀå µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦, »õ·Î¿î ±âȸ¿¡ ´ëÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â PET MRI ºÐ¾ß¸¦ ½ÉÃþÀûÀ¸·Î ºÐ¼®Çϰí 2024³âºÎÅÍ 2031³â±îÁö ½ÃÀå ±ËÀûÀ» °³°ýÇÏ´Â Áß¿äÇÑ Åë°è¿Í ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • PET MRI ½ÃÀå ±Ô¸ð(2024³â) : 2¾ï 1,250¸¸ ´Þ·¯
  • ½ÃÀå Àü¸ÁÄ¡(2031³â) : 4¾ï 850¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2031³â CAGR) : 9.78%.

PET MRI ½ÃÀå - Á¶»ç ¹üÀ§:

PET MRI ½ÃÀå

PET MRI ½ÃÀå¿¡´Â ¾çÀüÀÚ¹æ»ç¼±´ÜÃþÃÔ¿µ(PET) ±â¼ú°ú ÀÚ±â°ø¸í¿µ»ó(MRI) ±â¼úÀ» °áÇÕÇÑ Ã·´Ü À̹Ì¡ ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÇÏÀ̺긮µå À̹Ì¡ ¹æ½ÄÀº ¾Ï, ½Å°æ Áúȯ, ½ÉÇ÷°ü Áúȯ µî ´Ù¾çÇÑ ÁúȯÀÇ »ý¸®Àû, ÇØºÎÇÐÀû Ãø¸é¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº º´¿ø, ¿µ»óÁø´Ü¼¾ÅÍ ¹× ¿¬±¸±â°üÀ» ´ë»óÀ¸·Î Áø´Ü Á¤È®µµ, Ä¡·á °èȹ ¹× ȯÀÚ Ä¡·á¸¦ Çâ»ó½ÃŰ´Â ÃÖ÷´Ü PET MRI ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÃËÁø¿äÀÎ:

¼¼°è PET MRI ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ¾Ï ¹× ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº ¸¸¼º Áúȯ Áõ°¡·Î ÀÎÇØ Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á ¸ð´ÏÅ͸µÀ» À§ÇÑ Ã·´Ü ¿µ»ó ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, PET MRI ½Ã½ºÅÛÀº ¿ì¼öÇÑ ¿¬Á¶Á÷ ´ëºñ, ±â´ÉÀû ¿µ»ó ±â´É ¹× ºÐÀÚ ¿µ»ó ƯÀ̼ºÀ» Á¦°øÇÏ¿© Á¤È®ÇÑ Áúº´ Ư¼ºÈ­ ¹× Ä¡·á ¹ÝÀÀ Æò°¡¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. Á¤È®ÇÑ Áúº´ Ư¼º Æò°¡¿Í Ä¡·á ¹ÝÀÀ Æò°¡¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ÅëÇÕÇü ÇÏÀ̺긮µå ½ºÄ³³Ê, AI ±â¹Ý ¿µ»ó ºÐ¼® ¾Ë°í¸®Áò µî PET MRI Çϵå¿þ¾î ¹× ¼ÒÇÁÆ®¿þ¾îÀÇ ±â¼ú ¹ßÀüÀº Áø´Ü Á¤È®µµ, ¿öÅ©Ç÷οì È¿À²¼º, ȯÀÚ ÆíÀǼºÀ» Çâ»ó½ÃÄÑ ½ÃÀå µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À̹Ì¡ ±â¾÷, Çмú ±â°ü ¹× ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ °øµ¿ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê´Â ºÐÀÚ À̹Ì¡ ºÐ¾ßÀÇ Çõ½Å°ú ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

ÁÁÀº ½ÃÀå ¿ªÇп¡µµ ºÒ±¸Çϰí, PET MRI ½ÃÀåÀº °í°¡ÀÇ Àåºñ ÅõÀÚ, ±ÔÁ¦ Áؼö, »óȯ ºÒÈ®½Ç¼º µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, Àåºñ ±¸¸Å, ¼³Ä¡, À¯Áöº¸¼ö µî PET MRI ½Ã½ºÅÛÀÇ ³ôÀº Ãʱ⠺ñ¿ëÀ¸·Î ÀÎÇØ ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³°ú ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ PET MRI ½Ã½ºÅÛ µµÀÔÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. µµÀÔÀÌ Á¦ÇÑµÇ¾î ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, PET ¹æ»ç¼ºÀǾàǰÀÇ Á¦Á¶, ¹æ»ç¼± ¾ÈÀü ¹× ¿µ»ó ÇÁ·ÎÅäÄÝ Ç¥ÁØÈ­¿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°ÇÀº ¿µ»ó¼¾ÅÍ¿Í Á¦Á¶¾÷ü¿¡ ÄÄÇöóÀ̾𽺠ºÎ´ãÀ» °¡Áß½ÃÄÑ ¿î¿µÀÇ º¹À⼺À» ³ôÀÌ°í ½ÃÀå ÁøÀÔÀ» Áö¿¬½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ½Ã½ºÅÛ¸¶´Ù PET MRI °Ë»ç¿¡ ´ëÇÑ »óȯ Á¤Ã¥ÀÌ »óÀÌÇÏ¿© ȯÀÚÀÇ Á¢±Ù¿¡ ´ëÇÑ °æÁ¦Àû À庮°ú ¿µ»ó Á¦°ø¾÷ü¿¡ ´ëÇÑ »óȯÀÇ ºÒÈ®½Ç¼ºÀ» ¾ß±âÇÏ¿© ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

PET MRI ½ÃÀåÀº ±â¼ú Çõ½Å, ÀÓ»ó ¿¬±¸, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ À¯¸ÁÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, PET MRI µ¿½Ã ÃÔ¿µ, ¹æ»ç¼º ºÐ¼®, ¼¼¶ó¹Í ÀÀ¿ë°ú °°Àº »õ·Î¿î Æ®·»µå´Â Á¤¹ÐÀÇ·á ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·á Á¦°øÀÇ »õ·Î¿î ±æÀ» ¿­¾îÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÇÏÀ̺긮µå À̹Ì¡ ¿¬±¸, ¹æ»ç¼º ÃßÀûÀÚ °³¹ß, ºÐÀÚ À̹Ì¡ ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ ÅõÀÚ´Â Áúº´ÀÇ Á¶±â ¹ß°ß, Ä¡·á °èÃþÈ­, Ä¡·á ¹ÝÀÀ ¿¹ÃøÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ½ÃÀå °³Ã´À» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, À̹Ì¡ ±â¾÷, Á¦¾à»ç, ¿¬±¸±â°ü °£ÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ Áß°³ ¿¬±¸, ÀÓ»ó½ÃÇè ¸ðÁý, ½Å±Ô PET MRI ¿ëµµ¿¡ ´ëÇÑ ±ÔÁ¦ ½ÂÀÎÀ» ÃËÁøÇÏ¿© ½ÃÀå Â÷º°È­¿Í ¼öÀÍ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • PET MRI ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ±â¼ú ¹ßÀü°ú ÀÓ»ó ¿¬±¸°¡ PET MRI ½Ã½ºÅÛ ¹× ¿ëµµÀÇ ÁøÈ­¸¦ ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?
  • ºÐÀÚ À̹Ì¡ ºÐ¾ß ½ÃÀå ÁøÃâ±â¾÷ÀÌ Á÷¸éÇÑ ÁÖ¿ä °úÁ¦¿Í ±âȸ´Â ¹«¾ùÀΰ¡?
  • PET MRI ½Ã½ºÅÛÀÌ °¡Àå ¼ºÀåÇÒ °¡´É¼ºÀÌ ³ôÀº Áö¿ª°ú ÀÇ·á ȯ°æÀº ¾îµðÀΰ¡?
  • ºÐÀÚ À̹Ì¡ °æÀï ȯ°æ¿¡¼­ ÁÖ¿ä ±â¾÷µéÀº Á¦Ç° Çõ½Å, ½ÃÀå ħÅõ ¹× ÀÓ»ó ¼º°ú¸¦ ³ôÀ̱â À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå Áß¿ä ¼º°ø ¿äÀΰú ½ÃÀå »óȲ

  • ÃÖ±Ù Á¦Ç° ¸±¸®½º
  • Áö¿ªº° ¼³Ä¡ ±â¹Ý
  • Á¦Á¶¾÷ü¿¡ ÀÇÇÑ ÇÁ·Î¸ð¼Ç Àü·«
  • ±ÔÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ PET MRI ½ÃÀå ¼ö¿ä ºÐ¼®(¼ö·®)°ú ¿¹Ãø, 2024-2031³â

  • °ú°Å ½ÃÀå ±Ô¸ð(¼ö·®) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(¼ö·®) ¿¹Ãø, 2024-2031³â
  • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®

Á¦6Àå ¼¼°èÀÇ PET MRI ½ÃÀå - °¡°Ý ºÐ¼®

  • Á¦Ç° À¯Çüº° Áö¿ªº° °¡°Ý ºÐ¼®
  • °¡°Ý ºÐ¼®
    • Á¦Á¶¾÷ü ·¹º§ °¡°Ý °áÁ¤
    • À¯Åë¾÷ü ·¹º§ °¡°Ý °áÁ¤
  • ¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©

Á¦7Àå ¼¼°èÀÇ PET MRI ½ÃÀå ¼ö¿ä(±Ý¾×¡¤±Ô¸ð) ºÐ¼®

  • °ú°Å ½ÃÀå(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå(±Ý¾×) ¿¹Ãø, 2024-2031³â

Á¦8Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ¹ë·ùüÀÎ
  • ½ÃÀå ¿ªÇÐ

Á¦9Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, Á¦Ç° À¯Çüº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • Integrated
    • ISeparate
    • IInsert
    • IHybrid
  • Á¦Ç° À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, PET À̹Ì¡ ±â¼ú À¯Çüº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • ±âÁ¸
    • TOF
  • PET À̹Ì¡ ±â¼ú À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, ¿µ»ó Ãëµæ À¯Çüº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(±Ý¾×°ú ¼ö·®) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • ½ÃÄö¼È PET MRI ½ºÄ³³Ê
    • µ¿½Ã PET MRI ½ºÄ³³Ê
  • ¿µ»ó Ãëµæ À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦12Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, ¿ëµµº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • ÀüÀÓ»ó PET MRI ½Ã½ºÅÛ
    • ÀÓ»ó¿ë PET MRI ½Ã½ºÅÛ
  • ¿ëµµº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦13Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ÇöÀç ¹× ÇâÈÄ ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • º´¿ø
    • Áø´Ü½ÇÇè½Ç
    • ¿¬±¸±â°ü
    • ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
  • ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦14Àå ¼¼°èÀÇ PET MRI ½ÃÀå ºÐ¼®, Áö¿ªº°

  • ¼­·Ð
  • °ú°Å ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®, 2019-2023³â
  • ÇöÀç ½ÃÀå ±Ô¸ð(±Ý¾×) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
  • Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦15Àå ºÏ¹ÌÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦16Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦17Àå À¯·´ÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦18Àå ³²¾Æ½Ã¾ÆÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦19Àå µ¿¾Æ½Ã¾ÆÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦20Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦21Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ PET MRI ½ÃÀå ºÐ¼®

Á¦22Àå ½ÅÈï ±¹°¡ÀÇ PET MRI ½ÃÀå ºÐ¼®

  • ¼­·Ð
    • ÁÖ¿ä ±¹°¡º° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
    • ¼¼°è ¹× ±¹°¡º° ¼ºÀå ºñ±³
  • Áß±¹ÀÇ PET MRI ½ÃÀå ºÐ¼®
    • ¼­·Ð
    • PEST ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(¼ö·®, ¸ÅÃâ) ºÐ¼®°ú ¿¹Ãø
      • Á¦Ç° À¯Çüº°
      • PET À̹Ì¡ ±â¼ú À¯Çüº°
      • ¿µ»ó Ãëµæº°
      • ¿ëµµº°
      • ÃÖÁ¾»ç¿ëÀÚº°
  • ÀεµÀÇ PET MRI ½ÃÀå ºÐ¼®
    • ¼­·Ð
    • PEST ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(¼ö·®, ¸ÅÃâ) ºÐ¼®°ú ¿¹Ãø
      • Á¦Ç° À¯Çüº°
      • PET À̹Ì¡ ±â¼ú À¯Çüº°
      • ¿µ»ó Ãëµæº°
      • ¿ëµµº°
      • ÃÖÁ¾»ç¿ëÀÚº°
  • ºê¶óÁúÀÇ PET MRI ½ÃÀå ºÐ¼®
    • ¼­·Ð
    • PEST ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ¸ÅÃâ ºñÀ² ºÐ¼®
    • ½ÃÀå ºÐ·ùº° ½ÃÀå ±Ô¸ð(¼ö·®, ¸ÅÃâ) ºÐ¼®°ú ¿¹Ãø
      • Á¦Ç° À¯Çüº°
      • PET À̹Ì¡ ±â¼ú À¯Çüº°
      • ¿µ»ó Ãëµæº°
      • ¿ëµµº°
      • ÃÖÁ¾»ç¿ëÀÚº°

Á¦23Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ±â¾÷ Tierº° ½ÃÀå ºÐ¼®(PET MRI)
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÀÔÁö ºÐ¼®

Á¦24Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï»çº° °¡°Ý ºÐ¼®
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀï »ó¼¼(ÀáÁ¤ ¸®½ºÆ®)
    • GE Healthcare
    • Siemens AG
    • Koninklijke Philips NV
    • United Imaging
    • Bruker
    • Mediso Ltd.
    • Aspect Imaging
    • Cubresa Inc.
    • inviscan SAS
    • MR Solutions

Á¦25Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú µÎÀÚ¾î

Á¦26Àå Á¶»ç ¹æ¹ý

LSH 24.05.27

Persistence Market Research offers a comprehensive analysis of the global PET MRI (Positron Emission Tomography Magnetic Resonance Imaging) Market, providing insights into market trends, growth drivers, challenges, and emerging opportunities. This study delves deep into the PET MRI sector, furnishing crucial statistics and projections that outline the market's trajectory from 2024 to 2031.

Key Insights:

  • PET MRI Market Size (2024): USD 212.5 Million
  • Projected Market Value (2031): USD 408.5 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 9.78%

PET MRI Market - Report Scope:

The PET MRI Market encompasses advanced imaging systems that combine positron emission tomography (PET) and magnetic resonance imaging (MRI) technologies. These hybrid imaging modalities offer comprehensive insights into the physiological and anatomical aspects of various diseases, including cancer, neurological disorders, and cardiovascular conditions. The market caters to hospitals, diagnostic imaging centers, and research institutions, providing cutting-edge PET MRI solutions to enhance diagnostic accuracy, therapeutic planning, and patient care.

Market Growth Drivers:

The global PET MRI Market experiences robust growth driven by several key factors. Increasing prevalence of chronic diseases, such as cancer and neurodegenerative disorders, propels demand for advanced imaging techniques for accurate diagnosis and treatment monitoring. PET MRI systems offer superior soft tissue contrast, functional imaging capabilities, and molecular imaging specificity, thereby enabling precise disease characterization and therapeutic response assessment. Moreover, technological advancements in PET MRI hardware and software, such as integrated hybrid scanners and AI-powered image analysis algorithms, enhance diagnostic accuracy, workflow efficiency, and patient comfort, driving market adoption. Additionally, collaborative research initiatives between imaging companies, academic institutions, and healthcare providers stimulate innovation and market expansion in the field of molecular imaging.

Market Restraints:

Despite favorable market dynamics, the PET MRI Market faces challenges related to high capital investment, regulatory compliance, and reimbursement uncertainties. The substantial upfront costs associated with PET MRI systems, including equipment purchase, installation, and maintenance, limit adoption among small-scale healthcare facilities and resource-constrained regions, hindering market growth. Moreover, regulatory requirements for PET radiopharmaceutical production, radiation safety, and imaging protocol standardization impose compliance burdens on imaging centers and manufacturers, leading to operational complexities and delayed market entry. Furthermore, reimbursement policies for PET MRI procedures vary across different healthcare systems, posing financial barriers to patient access and reimbursement uncertainties for imaging providers, thereby impeding market expansion.

Market Opportunities:

The PET MRI Market offers promising opportunities driven by technological innovation, clinical research, and strategic partnerships. Emerging trends such as simultaneous PET MRI imaging, radiomics analysis, and theranostics applications unlock new avenues for precision medicine and personalized healthcare delivery. Moreover, investments in hybrid imaging research, radiotracer development, and molecular imaging biomarkers enable early disease detection, treatment stratification, and therapy response prediction, fostering market growth. Additionally, strategic collaborations between imaging companies, pharmaceutical firms, and research organizations facilitate translational research, clinical trial recruitment, and regulatory approval for novel PET MRI applications, driving market differentiation and revenue growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PET MRI Market globally?
  • How are technological advancements and clinical research shaping the evolution of PET MRI systems and applications?
  • What are the key challenges and opportunities facing market participants in the molecular imaging segment?
  • Which geographic regions and healthcare settings offer the highest growth potential for PET MRI systems?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of molecular imaging?

Competitive Intelligence and Business Strategy:

Leading players in the global PET MRI Market, including medical imaging companies, research institutions, and pharmaceutical enterprises, focus on innovation, clinical validation, and market expansion to gain a competitive advantage. These companies invest in R&D to develop next-generation PET MRI systems, radiopharmaceutical tracers, and imaging protocols tailored to clinical needs and regulatory requirements. Moreover, strategic collaborations with academic centers, healthcare providers, and regulatory agencies enable technology validation, clinical evidence generation, and market access for PET MRI solutions. Furthermore, emphasis on education, training, and clinical support services fosters user adoption, quality assurance, and patient safety in the dynamic landscape of molecular imaging.

Key Companies Profiled:

  • GE Healthcare
  • Siemens AG
  • Koninklijke Philips N.V.
  • United Imaging
  • Bruker
  • Mediso Ltd.
  • Aspect Imaging
  • Cubresa Inc.
  • Inviscan SAS
  • MR Solutions

PET MRI Market Segmentation

PET MRI Market by Product Type

  • Integrated
  • Separate
  • Insert
  • Hybrid

PET MRI Market by PET Imaging Technology

  • Conventional
  • Time of Flight

PET MRI Market by Image Acquisition

  • Sequential PET MRI Scanners
  • Simultaneous PET MRI Scanners

PET MRI by Application

  • Pre-clinical PET MRI Systems
  • Clinical Pet MRI Systems

PET MRI Market by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Biopharmaceutical Co.

PET MRI Market by Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors and Market Context

  • 4.1. Recent Product Launches
  • 4.2. Install Base by Region
  • 4.3. Promotional Strategies, by Manufacturers
  • 4.4. Regulatory Scenario

5. Global PET MRI Market Demand Analysis (Volume) and Forecast, 2024-2031

  • 5.1. Historical Market Volume (Mn Units) Analysis, 2019-2023
  • 5.2. Current and Future Market Volume (Mn Units) Projections, 2024-2031
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global PET MRI Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis By Product Type
  • 6.2. Pricing Break-up
    • 6.2.1. Manufacturer Level Pricing
    • 6.2.2. Distributor Level Pricing
  • 6.3. Global Average Pricing Analysis Benchmark

7. Global PET MRI Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global Healthcare Spending Outlook
    • 8.1.2. Global Pharmaceutical Outlook
    • 8.1.3. Regional Healthcare Market Outlook
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Increasing Healthcare Awareness
    • 8.2.2. Increasing Per-Capita Healthcare Expenditure
    • 8.2.3. Increasing Prevalence of Cancer
    • 8.2.4. Increasing Number of Diagnostic Laboratories
  • 8.3. Value Chain
  • 8.4. Market Dynamics
    • 8.4.1. Drivers
    • 8.4.2. Restraints
    • 8.4.3. Opportunity Analysis

9. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product Type, 2024-2031
    • 9.3.1. Integrated
    • 9.3.2. Separate
    • 9.3.3. Insert
    • 9.3.4. Hybrid
  • 9.4. Market Attractiveness Analysis By Product Type

10. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by PET Imaging Technology Type

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By PET Imaging Technology Type, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By PET Imaging Technology Type, 2024-2031
    • 10.3.1. Conventional
    • 10.3.2. Time of Flight
  • 10.4. Market Attractiveness Analysis By PET Imaging Technology Type

11. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by Image Acquisition Type

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Image Acquisition Type, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Image Acquisition Type, 2024-2031
    • 11.3.1. Sequential PET MRI Scanners
    • 11.3.2. Simultaneous PET MRI Scanners
  • 11.4. Market Attractiveness Analysis By Image Acquisition Type

12. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 12.3.1. Preclinical PET MRI Systems
    • 12.3.2. Clinical PET MRI Systems
  • 12.4. Market Attractiveness Analysis By Application

13. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 13.3.1. Hospitals
    • 13.3.2. Diagnostic Laboratories
    • 13.3.3. Research Institutes
    • 13.3.4. Biopharmaceutical Companies
  • 13.4. Market Attractiveness Analysis By End User

14. Global PET MRI Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. East Asia
    • 14.3.5. South Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis By Region

15. North America PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Product Type
    • 15.3.3. By PET Imaging Technology Type
    • 15.3.4. By Image Acquisition
    • 15.3.5. By Application
    • 15.3.6. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping

16. Latin America PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Product Type
    • 16.3.3. By Application
    • 16.3.4. By PET Imaging Technology Type
    • 16.3.5. By Image Acquisition
    • 16.3.6. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping

17. Europe PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. U.K
      • 17.3.1.2. Germany
      • 17.3.1.3. France
      • 17.3.1.4. Italy
      • 17.3.1.5. Spain
      • 17.3.1.6. Russia
      • 17.3.1.7. Rest of Europe
    • 17.3.2. By Product Type
    • 17.3.3. By PET Imaging Technology Type
    • 17.3.4. By Image Acquisition
    • 17.3.5. By Application
    • 17.3.6. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping

18. South Asia PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Thailand
      • 18.3.1.3. Indonesia
      • 18.3.1.4. Malaysia
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product Type
    • 18.3.3. By Application
    • 18.3.4. By PET Imaging Technology Type
    • 18.3.5. By Image Acquisition
    • 18.3.6. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping

19. East Asia PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Product Type
    • 19.3.3. By PET Imaging Technology Type
    • 19.3.4. By Image Acquisition
    • 19.3.5. By Application
    • 19.3.6. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping

20. Oceania PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Product Type
    • 20.3.3. By PET Imaging Technology Type
    • 20.3.4. By Image Acquisition
    • 20.3.5. By Application
    • 20.3.6. By End User
  • 20.4. Market Attractiveness Analysis
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping

21. Middle East and Africa PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 21.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. Northern Africa
      • 21.3.1.4. South Africa
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Product Type
    • 21.3.3. By PET Imaging Technology Type
    • 21.3.4. By Image Acquisition
    • 21.3.5. By Application
    • 21.3.6. By End User
  • 21.4. Market Attractiveness Analysis
  • 21.5. Market Trends
  • 21.6. Key Market Participants - Intensity Mapping

22. Emerging Countries PET MRI Market Analysis 2019-2023 and Forecast 2024-2031

  • 22.1. Introduction
    • 22.1.1. Market Value Proportion Analysis, By Key Countries
    • 22.1.2. Global Vs. Country Growth Comparison
  • 22.2. China PET MRI Market Analysis
    • 22.2.1. Introduction
    • 22.2.2. PEST Analysis
    • 22.2.3. Market Value Proportion Analysis by Market Taxonomy
    • 22.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 22.2.4.1. By Product Type
      • 22.2.4.2. By PET Imaging Technology Type
      • 22.2.4.3. By Image Acquisition
      • 22.2.4.4. By Application
      • 22.2.4.5. By End User
  • 22.3. India PET MRI Market Analysis
    • 22.3.1. Introduction
    • 22.3.2. PEST Analysis
    • 22.3.3. Market Value Proportion Analysis by Market Taxonomy
    • 22.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 22.3.4.1. By Product Type
      • 22.3.4.2. By PET Imaging Technology Type
      • 22.3.4.3. By Image Acquisition
      • 22.3.4.4. By Application
      • 22.3.4.5. By End User
  • 22.4. Brazil PET MRI Market Analysis
    • 22.4.1. Introduction
    • 22.4.2. PEST Analysis
    • 22.4.3. Market Value Proportion Analysis by Market Taxonom
    • 22.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 22.4.4.1. By Product Type
      • 22.4.4.2. By PET Imaging Technology Type
      • 22.4.4.3. By Image Acquisition
      • 22.4.4.4. By Application
      • 22.4.4.5. By End User

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies (PET MRI)
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis
    • 23.3.1. By Regional footprint of Players
    • 23.3.2. Product foot print by Players
    • 23.3.3. Channel Foot Print by Players

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Pricing Analysis by Competition
  • 24.3. Competition Benchmarking
  • 24.4. Competition Deep Dive (Tentative List)
    • 24.4.1. GE Healthcare
      • 24.4.1.1. Overview
      • 24.4.1.2. Product Portfolio
      • 24.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.1.4. Sales Footprint
      • 24.4.1.5. Strategy Overview
        • 24.4.1.5.1. Marketing Strategy
        • 24.4.1.5.2. Product Strategy
        • 24.4.1.5.3. Channel Strategy
    • 24.4.2. Siemens AG
      • 24.4.2.1. Overview
      • 24.4.2.2. Product Portfolio
      • 24.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.2.4. Sales Footprint
      • 24.4.2.5. Strategy Overview
        • 24.4.2.5.1. Marketing Strategy
        • 24.4.2.5.2. Product Strategy
        • 24.4.2.5.3. Channel Strategy
    • 24.4.3. Koninklijke Philips N.V.
      • 24.4.3.1. Overview
      • 24.4.3.2. Product Portfolio
      • 24.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.3.4. Sales Footprint
      • 24.4.3.5. Strategy Overview
        • 24.4.3.5.1. Marketing Strategy
        • 24.4.3.5.2. Product Strategy
        • 24.4.3.5.3. Channel Strategy
    • 24.4.4. United Imaging
      • 24.4.4.1. Overview
      • 24.4.4.2. Product Portfolio
      • 24.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.4.4. Sales Footprint
      • 24.4.4.5. Strategy Overview
        • 24.4.4.5.1. Marketing Strategy
        • 24.4.4.5.2. Product Strategy
        • 24.4.4.5.3. Channel Strategy
    • 24.4.5. Bruker
      • 24.4.5.1. Overview
      • 24.4.5.2. Product Portfolio
      • 24.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.5.4. Sales Footprint
      • 24.4.5.5. Strategy Overview
        • 24.4.5.5.1. Marketing Strategy
        • 24.4.5.5.2. Product Strategy
        • 24.4.5.5.3. Channel Strategy
    • 24.4.6. Mediso Ltd.
      • 24.4.6.1. Overview
      • 24.4.6.2. Product Portfolio
      • 24.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.6.4. Sales Footprint
      • 24.4.6.5. Strategy Overview
        • 24.4.6.5.1. Marketing Strategy
        • 24.4.6.5.2. Product Strategy
        • 24.4.6.5.3. Channel Strategy
    • 24.4.7. Aspect Imaging
      • 24.4.7.1. Overview
      • 24.4.7.2. Product Portfolio
      • 24.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.7.4. Sales Footprint
      • 24.4.7.5. Strategy Overview
        • 24.4.7.5.1. Marketing Strategy
        • 24.4.7.5.2. Product Strategy
        • 24.4.7.5.3. Channel Strategy
    • 24.4.8. Cubresa Inc.
      • 24.4.8.1. Overview
      • 24.4.8.2. Product Portfolio
      • 24.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.8.4. Sales Footprint
      • 24.4.8.5. Strategy Overview
        • 24.4.8.5.1. Marketing Strategy
        • 24.4.8.5.2. Product Strategy
        • 24.4.8.5.3. Channel Strategy
    • 24.4.9. inviscan SAS
      • 24.4.9.1. Overview
      • 24.4.9.2. Product Portfolio
      • 24.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.9.4. Sales Footprint
      • 24.4.9.5. Strategy Overview
        • 24.4.9.5.1. Marketing Strategy
        • 24.4.9.5.2. Product Strategy
        • 24.4.9.5.3. Channel Strategy
    • 24.4.10. MR Solutions
      • 24.4.10.1. Overview
      • 24.4.10.2. Product Portfolio
      • 24.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 24.4.10.4. Sales Footprint
      • 24.4.10.5. Strategy Overview
        • 24.4.10.5.1. Marketing Strategy
        • 24.4.10.5.2. Product Strategy
        • 24.4.10.5.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦